Skip to main content
Top
Published in: Multidisciplinary Respiratory Medicine 1/2015

Open Access 01-12-2016 | Original research article

Most Italians attending a congress on health of elderly people do not know and do not recognize respiratory diseases

Authors: Nicola Ciancio, Claudio M. Sanguinetti, Franco Falcone, Claudio Taranto, Roberto Fasani, Fernando De Benedetto, Onofrio Resta, Fausto De Michele, Roberto Messina, Andrea Rossi, Stefano Nardini, Giuseppe Di Maria

Published in: Multidisciplinary Respiratory Medicine | Issue 1/2015

Login to get access

Abstract

Background

The present study reports the results of a survey jointly carried out by three Italian respiratory scientific associations (AIMAR, AIPO, SIMeR) together with an important Federation of elderly patients (FederAnziani) during the National Conference of Italian Court for Health Right held in Rimini from November 29th to December 1st, 2013. The survey, based on a spirometric examination preceded by a questionnaire on respiratory health, was conducted on elderly people coming from all Italian regions to attend the Conference.

Methods

Nine hundred forty-nine subjects (574 females and 375 males), mean age 66.2 ± 10.1 years, were interviewed and performed spirometric examination. There were 137 smokers (14.4 %). Mean value of Body Mass Index (BMI) was significantly higher in males (27.6 ± 6.6) than in females (26.3 ± 4.3).

Results

17.1 % (N = 143) of the studied subjects reported to be suffering from respiratory disease and the prevalent illnesses were asthma (31.5 %) and COPD/emphysema (24.5 %), but only 3.3 % of the whole surveyed group was able to identify COPD as a pulmonary disease, however without knowing its characteristics, while these were known by 0.5 % of the interviewed subjects only.
A high number of subjects, 22 % of whom were smokers, declared chronic sputum production. 10.2 % of the study group showed an obstructive defect at spirometry when the criterium of lower limit of the normal (LLN) was considered, whereas it was 12.4 % if the fixed limit of 0.70 was chosen. 64 % of the obstructed people thought they did not have any respiratory disease.

Conclusions

The results of this survey, able to spread the knowledge of respiratory diseases and spirometry in a wide sample of subjects for the most part scarcely aware of them, emphasize the need for a greater divulgation of respiratory issues among the general population.
Literature
1.
go back to reference Niederlander E. Cause of death in the EU. Statistics in focus –population and social conditions. Eurostat (European Communities). 2006;101:1–12. Niederlander E. Cause of death in the EU. Statistics in focus –population and social conditions. Eurostat (European Communities). 2006;101:1–12.
2.
go back to reference Bettoncelli G, Blasi F, Brusasco V, Centanni S, Corrado A, De Benedetto F, et al. The clinical and integrated management of COPD. An official document of AIMAR (Interdisciplinary Association for Research in Lung Disease), AIPO (Italian Association of Hospital Pulmonologists), SIMER (Italian Society of Respiratory Medicine), SIMG (Italian Society of General Medicine). Multidiscip Respir Med. 2014;9:25. Bettoncelli G, Blasi F, Brusasco V, Centanni S, Corrado A, De Benedetto F, et al. The clinical and integrated management of COPD. An official document of AIMAR (Interdisciplinary Association for Research in Lung Disease), AIPO (Italian Association of Hospital Pulmonologists), SIMER (Italian Society of Respiratory Medicine), SIMG (Italian Society of General Medicine). Multidiscip Respir Med. 2014;9:25.
3.
go back to reference Vestbo J, Hurd SS, Agusti A, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187:347–65.CrossRefPubMed Vestbo J, Hurd SS, Agusti A, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187:347–65.CrossRefPubMed
5.
go back to reference World Health Organization report. Global surveillance, prevention and control of chronic respiratory diseases. A comprehensive approach. Geneva: World Health Organization; 2007. World Health Organization report. Global surveillance, prevention and control of chronic respiratory diseases. A comprehensive approach. Geneva: World Health Organization; 2007.
6.
go back to reference Alonso J, Ferrer M, Gandek B, Ware Jr JE, Aaronson NK, Mosconi P, IQOLA Project Group. Health-related quality of life associated with chronic conditions in eight countries: results from the International Quality of Life Assessment (IQOLA) Project. Qual Life Res. 2004;13(2):283–98.CrossRefPubMed Alonso J, Ferrer M, Gandek B, Ware Jr JE, Aaronson NK, Mosconi P, IQOLA Project Group. Health-related quality of life associated with chronic conditions in eight countries: results from the International Quality of Life Assessment (IQOLA) Project. Qual Life Res. 2004;13(2):283–98.CrossRefPubMed
7.
go back to reference European Respiratory Society/European Lung Foundation. European Lung White Book. The First Comprehensive Survey on Respiratory Health in Europe. Loddenkemper R, Gibson GJ, Sibille Y, eds. Sheffield, European Respiratory Society Journals, 2003. European Respiratory Society/European Lung Foundation. European Lung White Book. The First Comprehensive Survey on Respiratory Health in Europe. Loddenkemper R, Gibson GJ, Sibille Y, eds. Sheffield, European Respiratory Society Journals, 2003.
8.
go back to reference Dal Negro RW, Tognella S, Tosatto R, Dionisi M, Turco P, Donner CF. Cost of Chronic Obstructive Pulmonary Disease (COPD) in Italy: the SIRIO study (Social Impact of Respiratory Integrated Outcomes). Respir Med. 2008;102:92–101.CrossRefPubMed Dal Negro RW, Tognella S, Tosatto R, Dionisi M, Turco P, Donner CF. Cost of Chronic Obstructive Pulmonary Disease (COPD) in Italy: the SIRIO study (Social Impact of Respiratory Integrated Outcomes). Respir Med. 2008;102:92–101.CrossRefPubMed
9.
go back to reference Lucioni C, Donner CF, De Benedetto F, Lusuardi M, Mazzi S, Paggiaro PL, et al. I costi della broncopneumopatia cronica ostruttiva: la fase prospettica dello studio ICE (Italian Costs for Exacerbations in COPD). Pharmacoeconomics-Italian Research Articles. 2005;7:119–34.CrossRef Lucioni C, Donner CF, De Benedetto F, Lusuardi M, Mazzi S, Paggiaro PL, et al. I costi della broncopneumopatia cronica ostruttiva: la fase prospettica dello studio ICE (Italian Costs for Exacerbations in COPD). Pharmacoeconomics-Italian Research Articles. 2005;7:119–34.CrossRef
10.
go back to reference Van Weel C. Underdiagnosis of asthma and COPD: is the general practitioner to blame? Monaldi Arch Chest Dis. 2002;57:65–8.PubMed Van Weel C. Underdiagnosis of asthma and COPD: is the general practitioner to blame? Monaldi Arch Chest Dis. 2002;57:65–8.PubMed
11.
go back to reference Van Schayck CP, Chavannes NH. Detection of asthma and chronic obstructive pulmonary disease in primary care. Eur Respir J Suppl. 2003;39:16s–22s.CrossRefPubMed Van Schayck CP, Chavannes NH. Detection of asthma and chronic obstructive pulmonary disease in primary care. Eur Respir J Suppl. 2003;39:16s–22s.CrossRefPubMed
12.
go back to reference Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet. 2004;364:613–20.CrossRefPubMed Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet. 2004;364:613–20.CrossRefPubMed
13.
go back to reference Sutherland ER, Cherniack RM. Management of chronic obstructive pulmonary disease. N Engl J Med. 2004;350:2689–97.CrossRefPubMed Sutherland ER, Cherniack RM. Management of chronic obstructive pulmonary disease. N Engl J Med. 2004;350:2689–97.CrossRefPubMed
14.
go back to reference Lusuardi M, Lucioni C, De Benedetto F, Mazzi S, Sanguinetti CM, Donner CF. GOLD severity stratification and risk of hospitalization for COPD exacerbations. Monaldi Arch Chest Dis. 2008;69:164–9.PubMed Lusuardi M, Lucioni C, De Benedetto F, Mazzi S, Sanguinetti CM, Donner CF. GOLD severity stratification and risk of hospitalization for COPD exacerbations. Monaldi Arch Chest Dis. 2008;69:164–9.PubMed
15.
go back to reference Caramori GB, Bettoncelli G, Tosatto R, Arpinelli F, Visonà G, Invernizzi G, et al. Underuse of spirometry by general practitioners for the diagnosis of COPD in Italy. Monaldi Arch Chest Dis. 2006;63:6–12. Caramori GB, Bettoncelli G, Tosatto R, Arpinelli F, Visonà G, Invernizzi G, et al. Underuse of spirometry by general practitioners for the diagnosis of COPD in Italy. Monaldi Arch Chest Dis. 2006;63:6–12.
16.
go back to reference Arne M, Lisspers K, Stallberg B, Boman G, Hedenström H, Janson C, et al. How often is diagnosis of COPD confirmed with spirometry? Respir Med. 2010;104:550–6.CrossRefPubMed Arne M, Lisspers K, Stallberg B, Boman G, Hedenström H, Janson C, et al. How often is diagnosis of COPD confirmed with spirometry? Respir Med. 2010;104:550–6.CrossRefPubMed
17.
go back to reference Damarla M, Celli BR, Mullerova HX, Pinto-Plata VM. Discrepancy in the use of confirmatory tests in patients hospitalized with the diagnosis of chronic obstructive pulmonary disease or congestive heart failure. Respir Care. 2006;51:1120–5.PubMed Damarla M, Celli BR, Mullerova HX, Pinto-Plata VM. Discrepancy in the use of confirmatory tests in patients hospitalized with the diagnosis of chronic obstructive pulmonary disease or congestive heart failure. Respir Care. 2006;51:1120–5.PubMed
18.
go back to reference Pierson DJ. Clinical practice guidelines for chronic obstructive pulmonary disease: a review and comparison of current resources. Respir Care. 2006;51:277–88.PubMed Pierson DJ. Clinical practice guidelines for chronic obstructive pulmonary disease: a review and comparison of current resources. Respir Care. 2006;51:277–88.PubMed
19.
go back to reference Lucas A, Smmenk F, Smeele I, Brouwer T, Van Schayk O. The validity of diagnostic support of an asthma/COPD service in primary care. Brit J Clin Pract. 2007;57:892–6. Lucas A, Smmenk F, Smeele I, Brouwer T, Van Schayk O. The validity of diagnostic support of an asthma/COPD service in primary care. Brit J Clin Pract. 2007;57:892–6.
20.
go back to reference Lusuardi M, De Benedetto F, Paggiaro P, Sanguinetti CM, Ferri P, Donner CF. A randomized controlled trial on office spirometry in asthma and COPD in standard general practice: data from spirometry in Asthma and COPD: a comparative evaluation Italian study. Chest. 2006;129:844–52.CrossRefPubMed Lusuardi M, De Benedetto F, Paggiaro P, Sanguinetti CM, Ferri P, Donner CF. A randomized controlled trial on office spirometry in asthma and COPD in standard general practice: data from spirometry in Asthma and COPD: a comparative evaluation Italian study. Chest. 2006;129:844–52.CrossRefPubMed
21.
go back to reference Sanguinetti CM, De Benedetto F, Donner CF, Nardini S, Visconti A. Pneumocafé project: an inquiry on current COPD diagnosis and management among General Practitioners in Italy through a novel tool for professional education. Multidiscip Respir Med. 2014;9:35. Sanguinetti CM, De Benedetto F, Donner CF, Nardini S, Visconti A. Pneumocafé project: an inquiry on current COPD diagnosis and management among General Practitioners in Italy through a novel tool for professional education. Multidiscip Respir Med. 2014;9:35.
22.
go back to reference Istituto Nazionale di Statistica. Condizioni di salute e ricorso ai servizi sanitari. Rilevamento 2005. Disponibile dal 31-1-2008 sul sito www.istat.it. Istituto Nazionale di Statistica. Condizioni di salute e ricorso ai servizi sanitari. Rilevamento 2005. Disponibile dal 31-1-2008 sul sito www.​istat.​it.
23.
go back to reference Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance - United States, 1971–2000. MMWR Surveill Summ. 2002;51:1–16. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance - United States, 1971–2000. MMWR Surveill Summ. 2002;51:1–16.
24.
go back to reference Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319–38.CrossRefPubMed Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319–38.CrossRefPubMed
25.
go back to reference Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26:948–68.CrossRefPubMed Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26:948–68.CrossRefPubMed
27.
go back to reference Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095–128.CrossRefPubMed Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095–128.CrossRefPubMed
29.
go back to reference U.S. Department of Health and Human Services. The Health Consequences of Smoking: A Report of the Surgeon General. Atlanta, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2004. U.S. Department of Health and Human Services. The Health Consequences of Smoking: A Report of the Surgeon General. Atlanta, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2004.
31.
go back to reference Nardini S, Annesi-Maesano I, Del Donno M, Delucchi M, Bettoncelli G, Lamberti V, et al. The AIMAR recommendations for early diagnosis of chronic obstructive respiratory disease based on the WHO/GARD model. Multidiscip Respir Med. 2014;9:46. Nardini S, Annesi-Maesano I, Del Donno M, Delucchi M, Bettoncelli G, Lamberti V, et al. The AIMAR recommendations for early diagnosis of chronic obstructive respiratory disease based on the WHO/GARD model. Multidiscip Respir Med. 2014;9:46.
32.
go back to reference Vandevoorde J, Verbanck S, Gijssels L, Schuermans D, Devroey D, De Backer J, et al. Early detection of COPD: a case finding study in general practice. Respir Med. 2007;10:525–30.CrossRef Vandevoorde J, Verbanck S, Gijssels L, Schuermans D, Devroey D, De Backer J, et al. Early detection of COPD: a case finding study in general practice. Respir Med. 2007;10:525–30.CrossRef
33.
go back to reference Geijer RM, Sachs AP, Hoes AW, Salomé PL, Lammers JW, Verheij TJ. Prevalence of undetected persistent airflow obstruction in male smokers 40–65 years old. Fam Pract. 2005;22:485–9.CrossRefPubMed Geijer RM, Sachs AP, Hoes AW, Salomé PL, Lammers JW, Verheij TJ. Prevalence of undetected persistent airflow obstruction in male smokers 40–65 years old. Fam Pract. 2005;22:485–9.CrossRefPubMed
Metadata
Title
Most Italians attending a congress on health of elderly people do not know and do not recognize respiratory diseases
Authors
Nicola Ciancio
Claudio M. Sanguinetti
Franco Falcone
Claudio Taranto
Roberto Fasani
Fernando De Benedetto
Onofrio Resta
Fausto De Michele
Roberto Messina
Andrea Rossi
Stefano Nardini
Giuseppe Di Maria
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Multidisciplinary Respiratory Medicine / Issue 1/2015
Electronic ISSN: 2049-6958
DOI
https://doi.org/10.1186/s40248-016-0062-3

Other articles of this Issue 1/2015

Multidisciplinary Respiratory Medicine 1/2015 Go to the issue

Original research article

Cost of persistent asthma in Italy

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.